Evidence map›Paper›PMID 24899725›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2014

Regulation of the VHL/HIF-1 pathway by DJ-1.

Mohammad Parsanejad, Yi Zhang, Dianbo Qu, Isabella Irrcher, Maxime W C Rousseaux, Hossein Aleyasin, Fatemeh Kamkar, Steve Callaghan, Ruth S Slack, Tak W Mak and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 44 citations in OpenAlex.

  1. Trial
  2. Progress of Immunotherapies in Parkinson's Disease.CNS neuroscience & therapeutics · 2026
    Review
  3. Neurobiology of exercise in Parkinson's disease.Journal of Parkinson's disease · 2026
    Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Atypical Ubiquitination and Parkinson's Disease.International journal of molecular sciences · 2022
    Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Mohammad ParsanejadDepartment of Cellular and Molecular Medicine.
Yi ZhangDepartment of Cellular and Molecular Medicine.
Dianbo QuDepartment of Cellular and Molecular Medicine.
Isabella IrrcherDepartment of Cellular and Molecular Medicine, Department of Ophthalmology, Queen's University, Kingston, Ontario K7L 5G2, Canada.
Maxime W C RousseauxDepartment of Cellular and Molecular Medicine.
Hossein AleyasinDepartment of Cellular and Molecular Medicine.
Fatemeh KamkarDepartment of Cellular and Molecular Medicine.
Steve CallaghanDepartment of Cellular and Molecular Medicine.
Ruth S SlackDepartment of Cellular and Molecular Medicine.
Tak W MakThe Campbell Family Institute for Breast Cancer Research, Toronto, Ontario M5G 2C1, Canada, and.
Stephen LeeDepartment of Cellular and Molecular Medicine.
Daniel FigeysInstitute of Systems Biology, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada.ORCID http://orcid.org/0000-0002-5373-7546
David S ParkDepartment of Cellular and Molecular Medicine, Department of Cogno-Mechatronics Engineering, Pusan National University, Busan 609-735, Korea dpark@uottawa.ca.
Ontario Institute for Cancer Research · CAPusan National University · KRQueen's University · CAUniversity of Ottawa · CA

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

DJ-1 (PARK7) is a gene linked to autosomal recessive Parkinson disease (PD). We showed previously that DJ-1 loss sensitizes neurons in models of PD and stroke. However, the biochemical mechanisms underlying this protective role are not completely clear. Here, we identify Von Hippel Lindau (VHL) protein as a critical DJ-1-interacting protein. We provide evidence that DJ-1 negatively regulates VHL ubiquitination activity of the α-subunit of hypoxia-inducible factor-1 (HIF-1α) by inhibiting HIF-VHL interaction. Consistent with this observation, DJ-1 deficiency leads to lowered HIF-1α levels in models of both hypoxia and oxidative stress, two stresses known to stabilize HIF-1α. We also demonstrate that HIF-1α accumulation rescues DJ-1-deficient neurons against 1-methyl-4-phenylpyridinium-induced toxicity. Interestingly, lymphoblast cells extracted from DJ-1-related PD patients show impaired HIF-1α stabilization when compared with normal individuals, indicating that the DJ-1-VHL link may also be relevant to a human context. Together, our findings delineate a model by which DJ-1 mediates neuronal survival by regulation of the VHL-HIF-1α pathway.

Indexed as

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineAnimalsCells, CulturedEmbryo, MammalianFemaleGene Expression RegulationHumansHypoxia-Inducible Factor 1, alpha SubunitMaleMiceMice, KnockoutNeuroblastomaNeuronsNeurotoxinsOncogene ProteinsOxidative Stress1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineHif1a protein, mouseHypoxia-Inducible Factor 1, alpha SubunitNeurotoxinsOncogene ProteinsPARK7 protein, mousePeroxiredoxinsProtein Deglycase DJ-1Von Hippel-Lindau Tumor Suppressor ProteinDJ-1oxidative stressParkinson's disease

Identifiers

PMID24899725
PMCPMC6608259
OpenAlexW1984469528

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.